Jonathan Samuel Vogelgsang, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 26 | 2024 | 8717 | 1.890 |
Why?
|
Amyloid beta-Peptides | 18 | 2024 | 3886 | 1.820 |
Why?
|
Peptide Fragments | 12 | 2024 | 5141 | 1.140 |
Why?
|
Immunoassay | 4 | 2020 | 744 | 0.830 |
Why?
|
tau Proteins | 12 | 2023 | 2106 | 0.810 |
Why?
|
Dementia | 5 | 2022 | 2741 | 0.810 |
Why?
|
Blood Specimen Collection | 1 | 2020 | 238 | 0.610 |
Why?
|
Amyloid beta-Protein Precursor | 3 | 2021 | 1117 | 0.580 |
Why?
|
Dementia, Vascular | 1 | 2018 | 126 | 0.560 |
Why?
|
Apolipoproteins E | 6 | 2022 | 1459 | 0.560 |
Why?
|
Luminescent Measurements | 1 | 2018 | 342 | 0.520 |
Why?
|
Arthritis | 1 | 2019 | 684 | 0.440 |
Why?
|
Mood Disorders | 1 | 2019 | 1129 | 0.400 |
Why?
|
Exosomes | 3 | 2022 | 417 | 0.390 |
Why?
|
Patients | 1 | 2018 | 908 | 0.380 |
Why?
|
Germany | 4 | 2020 | 882 | 0.340 |
Why?
|
Immunoprecipitation | 4 | 2024 | 874 | 0.310 |
Why?
|
Inpatients | 1 | 2019 | 2563 | 0.290 |
Why?
|
Mental Disorders | 3 | 2021 | 6873 | 0.240 |
Why?
|
Electroconvulsive Therapy | 2 | 2020 | 505 | 0.230 |
Why?
|
Aged | 19 | 2024 | 171319 | 0.200 |
Why?
|
Aged, 80 and over | 10 | 2024 | 59548 | 0.200 |
Why?
|
Phosphorylation | 4 | 2023 | 8310 | 0.180 |
Why?
|
Nucleic Acids | 1 | 2024 | 189 | 0.180 |
Why?
|
Databases, Protein | 1 | 2021 | 390 | 0.160 |
Why?
|
Laboratory Proficiency Testing | 1 | 2018 | 20 | 0.160 |
Why?
|
ROC Curve | 2 | 2024 | 3618 | 0.150 |
Why?
|
Psychiatry | 2 | 2021 | 1715 | 0.150 |
Why?
|
Kallikreins | 1 | 2019 | 219 | 0.150 |
Why?
|
Protein Stability | 1 | 2020 | 578 | 0.150 |
Why?
|
Neurofilament Proteins | 1 | 2020 | 335 | 0.140 |
Why?
|
Middle Aged | 15 | 2024 | 223233 | 0.140 |
Why?
|
Humans | 39 | 2024 | 767040 | 0.140 |
Why?
|
Tomography | 1 | 2019 | 443 | 0.140 |
Why?
|
Male | 19 | 2024 | 364203 | 0.130 |
Why?
|
Capillaries | 1 | 2020 | 755 | 0.130 |
Why?
|
Female | 20 | 2024 | 396660 | 0.130 |
Why?
|
Astrocytes | 1 | 2024 | 1352 | 0.130 |
Why?
|
Spinal Puncture | 1 | 2018 | 284 | 0.130 |
Why?
|
Heterozygote | 2 | 2021 | 2794 | 0.130 |
Why?
|
Veins | 1 | 2020 | 769 | 0.120 |
Why?
|
Specimen Handling | 1 | 2020 | 706 | 0.120 |
Why?
|
Amyloidosis | 1 | 2022 | 876 | 0.110 |
Why?
|
Comorbidity | 2 | 2019 | 10582 | 0.110 |
Why?
|
Prevalence | 3 | 2022 | 15851 | 0.110 |
Why?
|
Prefrontal Cortex | 1 | 2024 | 2224 | 0.110 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12986 | 0.110 |
Why?
|
Multifactorial Inheritance | 1 | 2021 | 1422 | 0.100 |
Why?
|
Parkinsonian Disorders | 1 | 2015 | 285 | 0.100 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 15645 | 0.100 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 788 | 0.100 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 2 | 2024 | 157 | 0.100 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2021 | 1495 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3804 | 0.100 |
Why?
|
Memory Disorders | 1 | 2019 | 1193 | 0.100 |
Why?
|
Cost of Illness | 1 | 2021 | 1951 | 0.090 |
Why?
|
Delirium | 1 | 2022 | 1698 | 0.090 |
Why?
|
Reproducibility of Results | 5 | 2020 | 20169 | 0.090 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2020 | 1498 | 0.080 |
Why?
|
Pilot Projects | 2 | 2020 | 8732 | 0.080 |
Why?
|
Disease Progression | 2 | 2024 | 13646 | 0.080 |
Why?
|
Neurogenesis | 1 | 2015 | 863 | 0.080 |
Why?
|
alpha-Synuclein | 1 | 2015 | 773 | 0.080 |
Why?
|
Antidepressive Agents | 1 | 2020 | 2912 | 0.070 |
Why?
|
Computer Simulation | 1 | 2021 | 6260 | 0.070 |
Why?
|
Aging | 2 | 2024 | 8729 | 0.070 |
Why?
|
Cardiac Surgical Procedures | 1 | 2022 | 3683 | 0.070 |
Why?
|
Neurons | 2 | 2024 | 9517 | 0.070 |
Why?
|
Psychotic Disorders | 1 | 2021 | 3275 | 0.060 |
Why?
|
Depressive Disorder, Major | 2 | 2020 | 4813 | 0.060 |
Why?
|
Schizophrenia | 1 | 2024 | 6977 | 0.060 |
Why?
|
Health Care Costs | 1 | 2018 | 3239 | 0.060 |
Why?
|
Length of Stay | 1 | 2018 | 6489 | 0.060 |
Why?
|
Pandemics | 2 | 2021 | 8736 | 0.060 |
Why?
|
Synaptic Membranes | 1 | 2024 | 88 | 0.060 |
Why?
|
Genotype | 1 | 2019 | 13035 | 0.060 |
Why?
|
Sex Factors | 1 | 2018 | 10622 | 0.060 |
Why?
|
Cohort Studies | 4 | 2021 | 41718 | 0.060 |
Why?
|
Databases, Factual | 1 | 2019 | 8068 | 0.050 |
Why?
|
Threonine | 1 | 2023 | 272 | 0.050 |
Why?
|
Hippocampus | 1 | 2015 | 3777 | 0.050 |
Why?
|
Proteome | 2 | 2023 | 1890 | 0.050 |
Why?
|
Individuality | 1 | 2024 | 303 | 0.050 |
Why?
|
Proline | 1 | 2023 | 454 | 0.050 |
Why?
|
Carbohydrates | 1 | 2024 | 387 | 0.050 |
Why?
|
Amyloidogenic Proteins | 1 | 2022 | 151 | 0.050 |
Why?
|
Glutamine | 1 | 2024 | 575 | 0.050 |
Why?
|
Health | 1 | 2024 | 398 | 0.050 |
Why?
|
Synapses | 2 | 2024 | 1759 | 0.040 |
Why?
|
Neurofibrillary Tangles | 1 | 2023 | 457 | 0.040 |
Why?
|
Hypericum | 1 | 2020 | 58 | 0.040 |
Why?
|
Adult | 5 | 2024 | 223317 | 0.040 |
Why?
|
Neural Inhibition | 1 | 2024 | 589 | 0.040 |
Why?
|
Immunologic Tests | 1 | 2020 | 101 | 0.040 |
Why?
|
Young Adult | 3 | 2024 | 59980 | 0.040 |
Why?
|
Intermediate Filaments | 1 | 2020 | 171 | 0.040 |
Why?
|
Hospitalization | 1 | 2019 | 10815 | 0.040 |
Why?
|
Plasma | 1 | 2022 | 583 | 0.040 |
Why?
|
Least-Squares Analysis | 1 | 2020 | 369 | 0.040 |
Why?
|
Plaque, Amyloid | 1 | 2023 | 769 | 0.040 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2020 | 429 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2021 | 22254 | 0.040 |
Why?
|
Citalopram | 1 | 2020 | 402 | 0.040 |
Why?
|
Plant Extracts | 1 | 2020 | 496 | 0.030 |
Why?
|
Amyloid | 1 | 2022 | 849 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2020 | 950 | 0.030 |
Why?
|
Rats, Transgenic | 1 | 2015 | 70 | 0.030 |
Why?
|
Albumins | 1 | 2018 | 577 | 0.030 |
Why?
|
Positron-Emission Tomography | 2 | 2022 | 6550 | 0.030 |
Why?
|
Neuronal Plasticity | 1 | 2024 | 1446 | 0.030 |
Why?
|
Bromodeoxyuridine | 1 | 2015 | 310 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2021 | 856 | 0.030 |
Why?
|
Cholesterol | 1 | 2024 | 2905 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2022 | 2201 | 0.030 |
Why?
|
Exploratory Behavior | 1 | 2015 | 271 | 0.030 |
Why?
|
Cognition | 2 | 2024 | 7059 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3344 | 0.030 |
Why?
|
Glycoproteins | 1 | 2021 | 2200 | 0.030 |
Why?
|
Molecular Imaging | 1 | 2020 | 822 | 0.030 |
Why?
|
Lipids | 1 | 2024 | 3322 | 0.030 |
Why?
|
Autoantibodies | 1 | 2021 | 2114 | 0.030 |
Why?
|
Microscopy, Electron | 1 | 2015 | 2551 | 0.020 |
Why?
|
Microglia | 1 | 2021 | 1370 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2022 | 12790 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2021 | 81659 | 0.020 |
Why?
|
Cell Count | 1 | 2015 | 1825 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2015 | 2472 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3440 | 0.020 |
Why?
|
Serotonin | 1 | 2015 | 1045 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2024 | 18063 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2015 | 1074 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2021 | 3702 | 0.020 |
Why?
|
Metabolomics | 1 | 2020 | 1675 | 0.020 |
Why?
|
Risk Factors | 3 | 2022 | 74886 | 0.020 |
Why?
|
Neuropeptides | 1 | 2015 | 950 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 26325 | 0.020 |
Why?
|
Dopamine | 1 | 2015 | 1581 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2019 | 2647 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5022 | 0.020 |
Why?
|
Mental Health | 1 | 2021 | 3272 | 0.020 |
Why?
|
Brain | 2 | 2023 | 27163 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 7121 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13284 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14766 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2015 | 3207 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 16036 | 0.010 |
Why?
|
Depression | 1 | 2020 | 8234 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2022 | 15824 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 24299 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39317 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40154 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29963 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54886 | 0.010 |
Why?
|
Animals | 2 | 2021 | 168965 | 0.010 |
Why?
|
Child | 1 | 2021 | 80771 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 89046 | 0.010 |
Why?
|